Gary L. Carlson

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

Daniel M. Bloomfield, Gary L. Carlson, Aditi Sapre et al. · American Heart Journal · 2008 · 242 citations

Lipid Disorder, Cardiovascular Disease, Medicine +6

Safety and Efficacy of Long-Term Co-Administration of Fenofibrate and Ezetimibe in Patients With Mixed Hyperlipidemia

James M. McKenney, Michel Farnier, Kwok-Wing Lo et al. · Journal of the American College of Cardiology · 2006 · 107 citations

Drug Safety, Cardiovascular Disease, Mixed Hyperlipidemia +8

INDUCTION OF CYTOKINES IN CYNOMOLGUS MONKEYS BY THE IMMUNE RESPONSE MODIFIERS, IMIQUIMOD, S-27609 AND S-28463

Tamara L. Wagner, Vicki L. Horton, Gary L. Carlson et al. · Cytokine · 1997 · 75 citations

Inflammation, Cytokine, Autoimmune Disease +11

Real-World (RW) Multiple Myeloma (MM) Patients (Pts) Remain Under-Represented in Clinical Trials Based on Standard Laboratory Parameters and Baseline Characteristics: Analysis of over 3,000 Pts from the Insight MM Global, Prospective, Observational Study

Vânia Hungria, Hans C. Lee, Rafat Abonour et al. · Blood · 2019 · 19 citations

TNF alpha and IL-6 involvement in surgical trauma. II. In vitro cytokine production.

G Dimofte, Amanda F. Alexander, Gary L. Carlson et al. · PubMed · 2002 · 10 citations

Acute Lung Injury, Immune Regulation, Immunology +19